Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003862 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003862: Completed Phase 2 study, sponsored by Radiation Therapy Oncology Group.
NCT00003862 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003862, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy and radiation therapy in treating patients who have stomach cancer.
Interventions
- DRUG cisplatin
- DRUG paclitaxel
- DRUG fluorouracil
- DRUG leucovorin calcium
- PROCEDURE conventional surgery
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-11 |
| Phase | Phase 2 |
What the finished NCT00003862 record still lists
NCT00003862 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00003862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003862 about?
NCT00003862 is a clinical study titled "Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...
What is the current status of trial NCT00003862?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-11.
What interventions are being tested in trial NCT00003862?
The interventions under investigation include: cisplatin (DRUG), paclitaxel (DRUG), fluorouracil (DRUG), leucovorin calcium (DRUG), conventional surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00003862?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia